Alimera Sciences specialises in the commercialisation and development of prescription ophthalmic pharmaceuticals. Alimera Sciences is presently focused on diseases affecting the back of the eye, or retina, because these diseases may be insufficiently treated with current therapies and affect millions of people in our aging populations.

EUR-UNB-MMM-0067
Date of preparation: March 2019

For more information Contact us